Next-generation hybrid nanosystems for cannabidiol: From molecular challenges to site-specific preclinical applications

CBD’s therapeutic potential is constrained by a fundamental delivery problem: it dissolves poorly in water, undergoes extensive first-pass metabolism, and typically has low oral bioavailability. Researchers are now developing hybrid nanosystems designed to protect CBD, improve its stability and absorption, control its release, and potentially deliver it directly to specific sites in the body.

“Cannabidiol (CBD) is a monoterpene phenolic compound extracted mainly from Cannabis sativa, which is produced in high amounts compared to other plants. The compound is regarded as a promising therapeutic agent with anti-inflammatory, analgesic, and neuroprotective effects for biomedical use. Furthermore, important advances have been obtained in dermatological and anticancer effects.

Nowadays, the major challenges to the development of new medicine based on CBD arise from its unfavorable physicochemical properties that include reduced solubility in aqueous media (∼0.01 mg/mL), significant degradation due to first-pass metabolism, very low oral bioavailability (typically 6-20%), and an adverse pharmacokinetic profile. Seeking to overcome these disadvantages, recent studies have focused on employing delivery systems, including liposomes, polymeric nanoplatforms, and inorganic nanoparticles, which have attracted considerable attention for their excellent biocompatibility, high encapsulation capacity, and controlled-release properties.

Although conventional single-nanoplatforms offer advantages such as a large number of potential applications, they also have serious drawbacks, including burst drug release and short-term instability. Therefore, with respect to systems that will possess improved properties, hybrid nanoparticle systems have emerged as a second-generation class of systems capable of encapsulating CBD and potentially providing characteristics not available from single-nanoparticle systems. These include higher load efficiencies and stability, controlled and targeted delivery profiles, lower levels of premature drug release and greater enhancement of bioavailability. They are further able to provide site-specific delivery (i.e., transdermal, oral, or CNS-targeted).

The aim of this review is to provide readers with a simple summary of the most recent information found within the literature concerning CBD-loaded hybrid nanoparticle systems. It also discusses current preclinical evidence, translational challenges, and future perspectives for the clinical development of these systems.”

https://pubmed.ncbi.nlm.nih.gov/42659806

“Cannabidiol (CBD) constitutes one of the most promising therapeutic agents against different human diseases, mainly related to pathological conditions related to chronic inflammation, oxidative stress, and neurological dysregulation and degeneration, with relevant clinical results in epilepsy, autism, and pain management.”

“In summary, hybrid nanosystems have tremendous potential to transition cannabidiol delivery from traditional formulations to functional therapeutic platforms that deliver controlled release at the desired site of action while enhancing therapeutic performance.”

https://www.sciencedirect.com/science/article/pii/S0753332226009133?via%3Dihub

Quality by Design-Driven Formulation Development of Cannabidiol Orally Disintegrating Tablets

Orally disintegrating tablets may offer a more convenient way to deliver cannabidiol, particularly for people who have difficulty swallowing conventional pills. In this study, researchers used a Quality by Design approach to optimize a CBD tablet formulation for rapid disintegration, dose consistency, and reliable pharmaceutical performance.

“The development of cannabidiol (CBD) orally disintegrating tablets (ODTs) is effective in treating anxiety in a patient-friendly manner. The application of Quality by Design (QbD) enhances the efficiency and robustness of the pharmaceutical development of CBD ODTs.

The objective of this work was to develop a formulation for CBD ODTs using a QbD-driven approach. Quality target product profile, critical quality attributes, and an initial risk assessment were identified and evaluated. Subsequently, a Box-Behnken design was employed to analyze the effects of varied compression force, the quantity of microcrystalline cellulose, and the quantity of croscarmellose sodium to create a design space and control space.

Results indicated that the design and control spaces produced tablets with hardness ranging from 4 to 6 kg-force, a disintegration time (DT) ≤ 30 s, and a friability ≤ 1%. All formulations contained 4% CBD (or 10 mg per tablet). The optimal formulation consisted of 35% microcrystalline cellulose and 1% croscarmellose sodium and was compressed at 1400 pounds per square inch.

This formulation exhibited a hardness of approximately 5 kg-force, a DT of 13-15 s, and a friability of approximately 0.3%. Verification data confirmed the accuracy of the predictions made by computer software. The content uniformity and assay determined using validated high-performance liquid chromatography ranged between 90% and 100%. CBD was released from the CBD ODT in 1% sodium lauryl sulfate solution, with approximately 76% dissolved within 3 h in the dissolution study.

In conclusion, the QbD-driven approach successfully facilitated the formulation development of CBD ODTs with the desired properties for the treatment of anxiety in a patient-friendly manner.”

https://pubmed.ncbi.nlm.nih.gov/42662497

“The present study demonstrates the successful development of CBD ODTs using the QbD approach, which has proven effective in enhancing both the efficiency and robustness of the formulation process.

Overall, this study demonstrates the successful implementation of a QbD-driven strategy for laboratory-scale formulation development and optimization of CBD ODTs.

The findings contribute to pharmaceutical development efforts involving cannabinoid-based formulations and may provide useful guidance for future studies related to scale-up, stability evaluation, and in vivo performance.

https://onlinelibrary.wiley.com/doi/10.1155/sci5/3553253


Cannabis laws and health-related workplace absenteeism in the United States

A new U.S. study examining more than three decades of employment data found that medical cannabis decriminalization was associated with fewer health-related work absences, with some of the strongest effects appearing in physically demanding occupations and industries where chronic pain is common.

The findings suggest that access to medical cannabis may have implications not only for individual patients, but also for workforce participation and productivity.

“This study evaluated the impact of medical and recreational cannabis laws in the United States on health-related workplace absenteeism across different demographics, occupations, and industries.

Using state-level variation in the timing of cannabis decriminalization and the onset of regulated sales, we applied a flexible difference-in-differences approach to monthly data from the Current Population Survey, covering the period from January 1990 to March 2025.

The findings indicate that medical cannabis decriminalization reduced the likelihood of health-related work absences by about 6.9%, with decriminalization having a larger quantitative effect and greater statistical significance than the commencement of regulated sales.

We found no significant effect of recreational cannabis legalization on health-related workplace absenteeism. The absenteeism-reducing effects of medical cannabis decriminalization were notable in occupations (e.g., manual laborers, machine operators) and industries (e.g., manufacturing, agriculture, construction) where conditions more predisposed to cannabis treatment (e.g., chronic pain associated with physical work) are prevalent.”

https://www.tandfonline.com/doi/full/10.1080/15555240.2026.2680016#abstract

“University of Georgia study links legal marijuana use to fewer sick days”

https://www.livenowfox.com/news/university-georgia-study-links-legal-marijuana-use-fewer-sick-days

Essential Oils from Seed-Depleted Infructescences of Industrial Hemp: Chemical Diversity and Biological Potential

Industrial hemp is increasingly being studied not only for cannabinoids, fiber and seed products, but also for valuable compounds that can be recovered from plant material often treated as agricultural waste.

In this study, researchers examined essential oils obtained from seed-depleted hemp infructescences and found substantial chemical diversity along with antioxidant and antimicrobial activity. The results suggest that this underused post-harvest material may have potential value in pharmaceutical, cosmetic and oral healthcare applications.

The findings also highlight another way hemp biomass could be more fully utilized rather than discarded.

“Industrial hemp is a chemically rich plant increasingly explored within sustainable production systems aimed at the full utilization of all plant fractions. While hemp inflorescences have been extensively investigated, the biological potential of seed-depleted infructescences remains largely underexplored.

This study compared essential oils (EOs) distilled from inflorescences and seed-depleted infructescences of hemp (Cannabis sativa L. cv. Futura 75).

Their chemical composition was determined by gas chromatography-mass spectrometry (GC-MS), and their cytotoxicity, hemocompatibility, effects on blood coagulation, and antibacterial activity against a panel of 11 Gram-positive, Gram-negative, and microaerophilic bacterial strains were evaluated.

The major EO constituents included α-Pinene, (E)-Caryophyllene, Myrcene, α-Humulene, Caryophyllene oxide, and Cannabidiol.

EOs obtained from seed-depleted infructescences exhibited distinct chemical profiles, low cytotoxicity toward BJ human skin fibroblasts, minimal haemolytic activity, no significant effects on blood coagulation, and, in most cases, stronger antibacterial activity than inflorescence-derived EOs. Particularly high activity was observed against skin- and oral-associated bacteria, including Cutibacterium acnes and Streptococcus species.

These findings demonstrate that seed-depleted infructescences represent underutilized post-harvest biomass and a valuable and sustainable source of biologically active EOs, supporting their further investigation for potential pharmaceutical, cosmetic, and oral healthcare applications.”

https://pubmed.ncbi.nlm.nih.gov/42653967

https://link.springer.com/article/10.1007/s13365-026-01338-2


Therapeutic Potential of Cannabidiol in Dysbiosis-Related Oral Biofilm Diseases: Antibiofilm, Antivirulence and Host Response Evidence

Dental caries and periodontal disease are driven in part by harmful shifts in the microbial communities that form oral biofilms, making new approaches to controlling those biofilms an important area of research.

In this review, researchers examined the therapeutic potential of cannabidiol (CBD) and found evidence that it may inhibit biofilm formation, reduce microbial virulence, modulate periodontal inflammation and support tissue-protective responses.

The findings highlight CBD as a potential future adjunct for oral health, particularly in conditions linked to microbial dysbiosis such as tooth decay and periodontal disease.

“Dysbiosis-related oral biofilm diseases, particularly dental caries and periodontal diseases, pose major global health challenges because ecological shifts within oral microbial communities enhance biofilm virulence, resilience, and host inflammatory responses.

Cannabidiol (CBD), a non-psychoactive phytocannabinoid with antimicrobial, antibiofilm, immunomodulatory, and antioxidant properties, has attracted increasing interest as an investigational, ecology-oriented adjunct for oral health applications.

This narrative review evaluates current antibiofilm, antivirulence, and host response evidence for CBD in dysbiosis-related oral biofilm diseases, with emphasis on dental caries and periodontal diseases and selected supportive evidence from other oral biofilm-associated conditions.

Current evidence suggests that CBD can inhibit biofilm formation, attenuate cariogenic and fungal virulence traits, modulate periodontal inflammation and immunity, and support tissue-protective responses. However, most evidence remains preclinical and model-dependent, particularly in caries research, and CBD’s hydrophobicity, limited stability, uncertain dose windows, and incomplete microbiome-level evidence remain major barriers to translation.

Future studies should clarify CBD’s ecological effects on oral microbial communities, define clinically relevant dosing and exposure timing, and develop oral-retentive delivery systems.”

“Cannabidiol (CBD), a non-psychoactive phytocannabinoid with multi-target pharmacological properties, including rebalancing gut microbial homeostasis, anti-inflammatory, immunoregulatory, and antioxidant effects, has garnered attention in dentistry, particularly regarding dysbiosis-related oral biofilm diseases.”

“Accumulating evidence supports further investigation of CBD in dysbiosis-related oral biofilm diseases, particularly dental caries and periodontal diseases.”

https://www.mdpi.com/1424-8247/19/8/1221

Cannabis sativa-mediated biosynthesis of copper-zinc-selenium nanocomposites: phytochemical profiling, antioxidant properties, and molecular docking insights

Cannabis is being explored not only for its cannabinoids, but also as a biological tool for creating new materials with potential medical and industrial applications.

In this study, researchers used Cannabis sativa floral biomass extract to help synthesize copper-zinc-selenium nanocomposites. Chemical profiling identified multiple cannabis-derived compounds, including THC, CBD and CBN, while the resulting nanocomposites demonstrated antioxidant activity and promising molecular interactions in docking analyses.

The findings highlight another emerging use of cannabis plant chemistry in nanotechnology and bioactive material development.

Background: Nanotechnology is an emerging field widely applied across various disciplines, including medicine, to develop cost-effective and innovative therapies by delivering therapeutic compounds to targeted sites. The integration of multiple metals can yield synergistic multifunctional properties.

Aims: This study focuses on the green synthesis of copper-zinc-selenium (Cu-Zn-Se) nanocomposite, which is a straightforward and reliable method compared to chemical, physical, and mechanical techniques. Cannabis sativa, a dioecious plant from the Cannabinaceae family, has garnered significant attention due to its pharmacological properties and global cultivation.

Methods: In this research, Phytochemical analysis of extracts was carried out using Gas chromatography-mass spectrometry analysis (GC-MS). After that, a trimetallic copper-zinc-selenium (Cu-Zn-Se) nanocomposite was successfully synthesized using the floral biomass extract of Cannabis sativa and characterized by using UV-Vis spectral analysis, Scanning Electron Microscopy (SEM), and FTIR spectroscopy. Further, the potential applications of the synthesized trimetallic nanoparticles were evaluated by assessing their antioxidant activities through DPPH Free Radical Scavenging Activity, Hydrogen Peroxide Scavenging Assay, Ferric Reducing Power Assay, and Phosphomolybdate Antioxidant Activity. In addition, Molecular docking studies were used to investigate the drug target interactions for antioxidant behaviour.

Results: The UV-Vis spectrum displayed overlapping bands at 230, 290, and 327 nm, confirming the successful synthesis of the nanocomposite. FTIR analysis revealed peaks corresponding to various functional groups, notably a band at 1621.37 cm – 1 indicating C = O carbonyl stretching from amides, and a band at 1427.91 cm – 1 associated with C = C stretching (in-ring) from aromatic structures. SEM imaging showed spherical particles with an average size of 40 to 60 nm. A dose-dependent increase in antioxidant activity for the Cu-Zn-Se nanocomposite, which surpassed that of the plant extract in all assays studied and was comparable to the standard ascorbic acid. Molecular docking studies supported the experimental findings by showing that the Cu-Zn-Se nanocomposite binds stably to the antioxidant target protein, suggesting enhanced antioxidant activity.

Conclusion: This study is among the first to report the green synthesis of a Cannabis sativa-mediated Cu-Zn-Se trimetallic nanocomposite, highlighting its strong antioxidant potential and interaction pathways at the molecular level. These findings contribute novel insights into sustainable nanomaterial development and underscore the biomedical promise of phytogenic trimetallic nanocomposites as potent antioxidant agent.”

https://pubmed.ncbi.nlm.nih.gov/41131581

“The present study successfully demonstrates the synthesis, characterization, and evaluation of the antioxidant activity of the Cu-Zn-Se nanocomposite using Cannabis sativa floral biomass extract. The GC-MS analysis effectively identified the presence of key cannabinoids (THC, CBD, and CBN) and terpenes in the cannabis extract. These compounds contribute to the overall effects and therapeutic potential of the cannabis sample.”

“These results signify the immense bioactive potential of the green synthesized Cu-Zn-Se nanocomposite using Cannabis sativa extract, which can find applications in the pharmaceutical and industrial fields.”

https://link.springer.com/article/10.1186/s42238-025-00320-9

Mechanical, Electrical, and Thermal Performance of Hemp Fiber-Reinforced Elium Biocomposites Modified with Activated Carbon Nanoparticles: Experiment and Simulation

Hemp fiber is increasingly being studied as a renewable reinforcement material for high-performance composites.

In this study, researchers combined hemp fabric with a recyclable thermoplastic resin and activated carbon nanoparticles to examine changes in mechanical strength, electrical behavior and thermal performance.

The results show how hemp-based biocomposites can be engineered for more advanced applications, expanding the plant’s potential beyond traditional fiber products into lightweight, multifunctional materials.

“This research examines the influence of various concentrations (0%, 1%, 1.4% and 1.8% by weight) of activated carbon nanoparticles (AC NPs) on the performance of Elium biocomposites reinforced with hemp fibers.

Unidirectional [0°/0°] laminates with 20% fiber volume fraction were fabricated via hand layup using two layers of 150 GSM hemp fabric and compression molded to achieve 0.9 mm cured thickness.

Quasi-static tensile testing (ASTM D3039, 2 mm/min, 100 mm gauge length) revealed a pronounced non-monotonic relationship between AC NPs loading and mechanical properties, with optimal performance at 1.0 wt.% fillers and catastrophic degradation at 1.8 wt.%. AC NPs filled composites, which were then characterized by their electrical and thermal behavior.

Electrically, it also achieved minimum resistivity (1.62 Ω·m) and maximum conductivity (0.62 S·m-1), in contrast to the elevated resistance (42.5 kΩ) found in samples with a higher filler content.

Thermal analysis showed a slight effect on the degradation of the onset temperature (300 °C) and a higher charring after addition of AC NP. Finite element analysis (FEA) provided a corroboration for these experimental findings, with simulations verification.

Microscopy revealed cohesive fractures in the 1.0 wt.% composite whereas voids and brittle failure were evident in samples with higher loading. Hence, the concentration of 1.0 wt.% AC NP offers the best trade off of mechanical, electrical, and thermal properties.”

https://pubmed.ncbi.nlm.nih.gov/41516850

https://www.mdpi.com/2073-4360/18/1/66


In Situ Synthesis of ZnO Nanoparticles Using Soy Protein Isolate for Sustainable and Multifunctional Finishing of Hemp Fabrics

Hemp fabrics are increasingly being explored as sustainable materials that can be enhanced with added functional properties.

In this study, researchers used soy protein isolate to support the in-situ formation of zinc oxide nanoparticles directly on hemp fabric, creating a more sustainable finishing process.

The treated fabrics showed improved multifunctional performance, highlighting the potential for hemp textiles to be developed for advanced applications beyond conventional clothing and fiber products.

“This study presents an environmentally sustainable finishing approach for hemp fabrics by combining soy protein isolate (SPI) pretreatment with an in situ infrared (IR)-assisted synthesis of zinc oxide nanoparticles (ZnO NPs).

IR heating was employed to reduce energy consumption while promoting efficient nanoparticle formation compared to conventional thermal processing, while SPI acted as a bio-based stabilizer to enable uniform ZnO NP distribution on the fabric surface. Transmission electron microscopy revealed predominantly spherical to polyhedral ZnO NPs with minimal agglomeration, and X-ray diffraction confirmed their characteristic wurtzite crystalline structure. Scanning electron microscopy coupled with energy-dispersive X-ray spectroscopy mapping further verified the homogeneous deposition of ZnO NPs on hemp fibers.

The treated fabrics exhibited multifunctional performance, showing significantly enhanced ultraviolet (UV) protection with a UV protection factor (UPF) of 50+ compared with untreated hemp.

Antibacterial activity against Staphylococcus aureus and Escherichia coli was confirmed by the AATCC TM147 test, while a quantitative AATCC TM100 assessment demonstrated an excellent antibacterial efficiency of 99.99% bacterial reduction against S. aureus. Additionally, the incorporation of 2 wt% SPI significantly improved fabric hydrophilicity and wettability.

Overall, this work demonstrates a green and effective strategy for producing antibacterial and UV-protective hemp textiles.”

https://pubmed.ncbi.nlm.nih.gov/41516899

“This study successfully developed a novel antibacterial finishing process for hemp fabrics by combining SPI pretreatment with an IR-assisted in situ synthesis of ZnO NPs.”

“Consequently, this work provides a generalized and scalable framework for the development of eco-friendly antibacterial and UV-protective textile finishes.”

https://www.mdpi.com/2073-4360/18/1/116


Cannabidiol-Loaded Mucoadhesive PLGA Nanosphere-Chitosan Hydrogel Patch for Oral Therapeutic Applications

Delivering cannabidiol (CBD) directly to tissues inside the mouth could provide a new approach to treating inflammatory oral diseases such as gingivitis and periodontitis.

In this study, researchers developed a mucoadhesive hydrogel patch containing CBD-loaded nanospheres designed to remain attached to oral tissue and gradually release CBD. The formulation demonstrated sustained CBD release, improved mucosal permeability, strong antibacterial activity and reductions in inflammatory markers.

The findings highlight the potential of targeted CBD delivery systems for treating inflammation and supporting healing in the mouth.

“Cannabidiol (CBD), the primary bioactive element of cannabis, has shown promise in alleviating pain and inflammation, although mechanisms in periodontal inflammation are not fully understood.

To improve its limited solubility and mucosal permeability, the developed chitosan-based mucoadhesive hydrogel incorporating CBD-loaded PLGA nanospheres (CPN hydrogel) was characterized by FT-IR, SEM, particle size, rheological, swelling, and diffusion analyses, followed by biological evaluations, including wound-healing and RT-qPCR-based anti-inflammatory assays.

The improved CPN hydrogel had a homogeneous shape, better viscoelastic behavior, and sustained drug release. Over 90% of CBD was released within 96 h, and Franz cell experiments showed improved permeability (124.1 μg/cm2 after 72 h). The gellan gum-based mucosal substrate significantly increased adhesion (1137.33 ± 142.25 s) compared to the control groups.

Antioxidant studies indicated 73.65% DPPH radical scavenging, whereas antibacterial tests showed more than 99% suppression of Staphylococcus aureus. Furthermore, in vitro studies validated its wound healing and the downregulation of the inflammatory cytokines IL-6 and TNF-α.

The results indicate that the CPN-loaded chitosan hydrogel has extended mucosal retention, strong antibacterial activity, and steady release of CBD. This underscores its significant potential as a targeted treatment for inflammatory oral diseases such as gingivitis and periodontitis.”

https://pubmed.ncbi.nlm.nih.gov/41596768

“Cannabidiol (CBD), a non-psychoactive phytocannabinoid from Cannabis sativa with anti-inflammatory, immunomodulatory, and antimicrobial properties, is a promising bioactive compound for oral health applications [9,10,11]. In addition, CBD not only reduces inflammation, but also fights P. gingivalis very well.”

https://www.mdpi.com/1422-0067/27/2/1127


Development of smart/active chitosan/Kapppa-carrageenan films incorporating Aronia anthocyanin and ginger essential oil Pickering emulsion stabilized by hempseed protein nanoparticles

Hempseed protein is finding new uses as a functional ingredient in sustainable food-packaging technologies.

In this study, researchers used hempseed protein nanoparticles to stabilize a ginger essential-oil nanoemulsion incorporated into an edible film designed to both protect food and indicate freshness. The resulting material showed improved antioxidant and antimicrobial activity, stronger barrier properties, and color changes in response to conditions associated with spoilage.

The findings highlight hempseed protein’s potential role in developing bio-based “smart” packaging that can help preserve food while also signaling changes in freshness.

“The present study aimed to develop a multipurpose edible film with active (antioxidant/antimicrobial) and intelligent (food freshness monitoring) capabilities.

A Pickering nanoemulsion containing ginger essential oil (PNGEO) was prepared using hempseed protein as a stabilizer.

The effect of incorporating varying concentrations of PNGEO (0%, 5%, 10%w/v) and Aronia anthocyanin extract (AE) (0%, 4%, 8%w/v) on the physicochemical properties of films were evaluated using RSM and CCD, then optimal samples were identified using the utility function method, and their properties were examined.

The results demonstrated that the PNGEO formed a stable O/W emulsion with a Z-potential of -18.3 mV, a particle size of 108 nm, and PDI of 0.44. The encapsulation efficiencies were 91.72% for PNGEO. The AE exhibited pH-responsive color changes, transitioning from red to green across a pH range of 2-13. Increasing the AE and PNGEO enhanced the films’ water vapor barrier, antioxidant and antimicrobial properties. Elongation at break and tensile strength increased from 19.21% to 45.89% and from 6.25 to 15.97 MPa, respectively.

The pH color changes and sensitivity to ammonia gas confirmed the smart functionality of films. SEM and FTIR revealed minor changes in the chemical structure and strong molecular interactions between the biopolymer matrix and the incorporated components. XRD and DSC analyses indicated an increase in crystallinity index and a slight reduction in thermal stability. Release kinetics studies showed that higher temperatures and GEO content can increase the release rate and D values.

In conclusion, the film containing 8% AE and 10% PNGEO showed the best performance by simultaneously providing improvements in antioxidant/antimicrobial properties and sensitive color response to volatile spoilage compounds, and is introduced as a bio-based system with dual capabilities for maintaining quality and monitoring food freshness.”

https://pubmed.ncbi.nlm.nih.gov/41904862

“A novel active/smart edible film based on chitosan/kappa-carrageenan was developed using a Pickering nanoemulsion containing ginger essential oil and stabilized with hempseed protein and aronia anthocyanin extract to enhance the biopolymer’s properties.”

https://www.sciencedirect.com/science/article/abs/pii/S0308814626009222?via%3Dihub